News

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
(CNN) — The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the ...
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
The new vaccine (mNexspike [COVID-19 Vaccine, mRNA]) represents a significant step forward in the development of next-generation coronavirus vaccines, the Associated Press reported.
The Food and Drug Administration has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike.
The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.